Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.820
+0.010 (0.55%)
At close: Sep 26, 2025, 4:00 PM EDT
1.840
+0.020 (1.09%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Propanc Biopharma Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Selling, General & Admin | 53.67 | 1.29 | 1.53 | 1.73 | 1.58 | 3.31 | |
| Research & Development | 0.22 | 0.25 | 0.25 | 0.26 | 0.23 | 0.18 | |
| Operating Expenses | 53.89 | 1.54 | 1.78 | 1.99 | 1.81 | 3.49 | |
| Operating Income | -53.89 | -1.54 | -1.78 | -1.99 | -1.81 | -3.49 | |
| Interest Expense | -0.4 | -0.67 | -0.53 | -0.57 | -0.45 | -1.75 | |
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0 | 0 | |
| Currency Exchange Gain (Loss) | -0.05 | 0.02 | 0.01 | -0.04 | 0.03 | -0.14 | |
| Other Non Operating Income (Expenses) | -0.05 | 0.18 | -0.53 | -0.1 | -0.01 | 0.44 | |
| EBT Excluding Unusual Items | -54.4 | -2 | -2.83 | -2.7 | -2.24 | -4.94 | |
| Other Unusual Items | -0.81 | 0.05 | 0.04 | -0.02 | 0.1 | 0.07 | |
| Pretax Income | -55.21 | -1.95 | -2.79 | -2.71 | -2.14 | -4.88 | |
| Income Tax Expense | -0 | -0.13 | -0.13 | -0.05 | -0.11 | -0.13 | |
| Net Income | -55.21 | -1.82 | -2.66 | -2.66 | -2.03 | -4.74 | |
| Preferred Dividends & Other Adjustments | - | 0.19 | 0.47 | 0.7 | 0.39 | - | |
| Net Income to Common | -55.21 | -2.01 | -3.13 | -3.36 | -2.42 | -4.74 | |
| Free Cash Flow | -0.64 | -0.94 | -1.11 | -1.44 | -1.15 | -1.85 | |
| EBITDA | -53.89 | -1.54 | -1.77 | -1.99 | -1.81 | -3.49 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -53.89 | -1.54 | -1.78 | -1.99 | -1.81 | -3.49 | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.